日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials

来自LYSA研究组的混合临床试验和真实世界数据的合成对照组，适用于80岁以上未经治疗的弥漫性大B细胞淋巴瘤患者：一项切实可行的创新临床试验策略

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01374-x
Letailleur, Valentin; Chaillol, Isabelle; Cherblanc, Fanny; Ghesquières, Hervé; Peyrade, Frédéric; Guidez, Stéphanie; Bijou, Fontanet; Sesques, Pierre; Rossi, Cédric; Fornecker, Luc-Matthieu; Fouillet, Ludovic; Carras, Sylvain; Chartier, Loïc; Belot, Aurélien; Oberic, Lucie; Jardin, Fabrice; Tessoulin, Benoit
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients

LOC-R01 的 IB 期部分，LOC-R01 是一项 LOC 网络非对照随机 IB/II 期研究，旨在测试 R-MPV 联合递增剂量的来那度胺或伊布替尼治疗新诊断的原发性中枢神经系统淋巴瘤 (PCNSL) 患者的疗效。

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-024-01606-w
Alcantara, Marion; Chevrier, Marion; Jardin, Fabrice; Schmitt, Anna; Houillier, Caroline; Oberic, Lucie; Chinot, Olivier; Morschhauser, Franck; Peyrade, Frédéric; Houot, Roch; Hoang-Xuan, Khê; Ghesquieres, Hervé; Soussain, Carole
淋巴瘤
神经科学
发表日期：2024
文献求助 收藏

Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients

更正：本研究为 LOC-R01 的 IB 期部分，LOC-R01 是一项 LOC 网络开展的非对照随机 IB/II 期研究，旨在评估 R-MPV 联合递增剂量的来那度胺或伊布替尼治疗新诊断的原发性中枢神经系统淋巴瘤 (PCNSL) 患者的疗效。

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-024-01620-y
Alcantara, Marion; Chevrier, Marion; Jardin, Fabrice; Schmitt, Anna; Houillier, Caroline; Oberic, Lucie; Chinot, Olivier; Morschhauser, Franck; Peyrade, Frédéric; Houot, Roch; Hoang-Xuan, Khê; Ghesquieres, Hervé; Soussain, Carole
淋巴瘤
神经科学
发表日期：2024
文献求助 收藏

Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT

一项观察性、前瞻性、4期研究，纳入接受西妥昔单抗联合铂类化疗一线治疗的复发性和/或转移性头颈部鳞状细胞癌患者：DIRECT

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.1467
Guigay, Joël; Chamorey, Emmanuel; Lefebvre, Gautier; Rotarski, Maciej; Wagner, Jean-Philippe; Blot, Emmanuel; Alfonsi, Marc; Seronde, Audrey; Schulten, Jeltje; Peyrade, Frédéric; Le Tourneau, Christophe
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study

伊布替尼联合维奈克拉治疗复发/难治性套细胞淋巴瘤：SYMPATICO III期研究的安全性导入期

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-021-01188-x
Wang, Michael; Ramchandren, Radhakrishnan; Chen, Robert; Karlin, Lionel; Chong, Geoffrey; Jurczak, Wojciech; Wu, Ka Lung; Bishton, Mark; Collins, Graham P; Eliadis, Paul; Peyrade, Frédéric; Lee, Yihua; Eckert, Karl; Neuenburg, Jutta K; Tam, Constantine S
细胞生物学
淋巴瘤
发表日期：2021
文献求助 收藏

Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer

目前关于提高接受癌症积极治疗患者SARS-CoV-2疫苗疗效的观点

期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2021.06.008
Barrière, Jérôme; Re, Daniel; Peyrade, Frédéric; Carles, Michel
SARS-CoV-2
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives

植物、真菌、藻类和蓝藻中的人类特异性凝集素作为SARS-CoV、MERS-CoV和SARS-CoV-2（COVID-19）冠状病毒的潜在阻断剂：生物医学视角

期刊:Cells
影响因子:5.2
doi:10.3390/cells10071619
Barre, Annick; Van Damme, Els J M; Simplicien, Mathias; Le Poder, Sophie; Klonjkowski, Bernard; Benoist, Hervé; Peyrade, David; Rougé, Pierre
微生物学
SARS-CoV-2
发表日期：2021
文献求助 收藏

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME

对于接受 EXTREME 方案治疗后病情进展的复发或转移性头颈部鳞状细胞癌患者，可使用西妥昔单抗联合紫杉醇或单用紫杉醇。

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.3953
Chevalier, Thomas; Daste, Amaury; Saada-Bouzid, Esmaa; Loundou, Anderson; Peyraud, Florent; Lambert, Tiphaine; Le Tourneau, Christophe; Peyrade, Frédéric; Dupuis, Charlotte; Alfonsi, Marc; Fayette, Jérôme; Reure, Juliette; Huguet, Florence; Fakhry, Nicolas; Toullec, Clémence; Salas, Sébastien
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

[We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment]

[我们必须尊重正在接受治疗的癌症患者的抗SARS-CoV-2疫苗接种计划，不得延误]

期刊:Bulletin Du Cancer
影响因子:0.8
doi:10.1016/j.bulcan.2021.02.003
Barrière, Jérôme; Audigier-Valette, Clarisse; Borchiellini, Delphine; Hoch, Benjamin; Castelnau, Olivier; Francois, Eric; Gastaud, Lauris; Skaf, Richard; Berdah, Jean-François; Marie, Wislez; Lescaut, Willy; Peyrade, Frédéric; Cluzeau, Thomas; Cassuto, Ophélie; Carles, Michel
SARS-CoV-2
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics

作者更正：免疫检查点抑制剂治疗下的超进展：生殖细胞免疫遗传学的潜在作用

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-020-66841-w
Refae, Sadal; Gal, Jocelyn; Brest, Patrick; Giacchero, Damien; Borchiellini, Delphine; Ebran, Nathalie; Peyrade, Frederic; Guigay, Joël; Milano, Gérard; Saada-Bouzid, Esma
Checkpoint
细胞生物学
免疫/内分泌
发表日期：2020
文献求助 收藏